Targeting fibroblast-growth-factor-receptor-dependent signaling for cancer therapy

Author： Heinzle Christine   Sutterlüüty Hedwig   Grusch Michael   Grasl-Kraupp Bettina   Berger Walter   Marian Brigitte  

Publisher： Informa Healthcare

ISSN： 1472-8222

Source： Expert Opinion on Therapeutic Targets, Vol.15, Iss.7, 2011-07, pp. : 829-846

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Targeting fibroblast growth factor receptor in breast cancer: a promise or a pitfall?

By Bedussi Francesca   Bottini Alberto   Memo Maurizio   Fox Stephen B   Sigala Sandra   Generali Daniele  

Expert Opinion on Therapeutic Targets, Vol. 18, Iss. 6, 2014-06 ,pp. : 665-678

Informa Healthcare

Access to resources Recommend Favorite

Is Fibroblast Growth Factor Receptor 4 a Suitable Target of Cancer Therapy?

By  

Current Pharmaceutical Design, Vol. 20, Iss. 17, 2014-05 ,pp. : 2881-2898

Bentham Science Publishers

Access to resources Recommend Favorite

ZD1839: targeting the epidermal growth factor receptor in cancer therapy

By Herbst Roy S  

Expert Opinion on Investigational Drugs, Vol. 11, Iss. 6, 2002-06 ,pp. : 837-849

Informa Healthcare

Access to resources Recommend Favorite

Crosstalk Between Epidermal Growth Factor Receptor- and Insulin-Like Growth Factor-1 Receptor Signaling: Implications for Cancer Therapy

By  

Current Cancer Drug Targets, Vol. 9, Iss. 6, 2009-09 ,pp. : 748-760

Bentham Science Publishers

Access to resources Recommend Favorite

Fibroblast Growth Factor Receptor Inhibitors

By  

Current Pharmaceutical Design, Vol. 19, Iss. 4, 2013-02 ,pp. : 687-701

Bentham Science Publishers

Access to resources Recommend Favorite